SEC Form 4 · accession 0000899243-15-004075
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ji
Officer — President and CEO · Director
Period of report
Aug 26, 2015
Accepted (ET)
Aug 26, 2015 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| SRNE 35 March 2016 Call Options | Aug 26, 2015 | P | 497 | $0.95 | A | 497 | D | |
| SRNE 35 March 2016 Call Options | Aug 26, 2015 | P | 3 | $0.50 | A | 500 | D |
Table II — derivative securities
No Table II lines on this filing.